Disease Overview：Intracerebral hemorrhage（ICH）
Intracerebral hemorrhage (ICH) is a life-threatening subtype of stroke characterized by spontaneous bleeding within the brain parenchyma, commonly resulting from hypertension-induced small vessel disease, cerebral amyloid angiopathy, or structural vascular anomalies such as arteriovenous malformations. Clinical presentation varies with hematoma location and volume but often includes sudden onset of headache, nausea, vomiting, focal neurological deficits (e.g., hemiparesis, aphasia), decreased consciousness, or seizures. Early diagnosis relies on non-contrast cranial CT to confirm hemorrhage and exclude mimics; MRI may further delineate underlying etiology. Acute management prioritizes blood pressure control, reversal of coagulopathy if present, neurocritical care monitoring, and timely neurosurgical intervention—such as minimally invasive hematoma evacuation or stereotactic aspiration—when indicated by size, location, or clinical deterioration. Prognosis depends heavily on baseline Glasgow Coma Scale score, hematoma volume, intraventricular extension, and timeliness of intervention.
China offers distinct advantages for ICH treatment: leading neurology and neurosurgery centers—many accredited by JCI or ISO—employ advanced multimodal imaging (3T MRI, perfusion CT), intraoperative neuronavigation, and robotic-assisted endoscopic techniques. High-volume tertiary hospitals report 30-day mortality rates comparable to top Western institutions, with published outcomes demonstrating improved functional independence at 90 days following protocol-driven neurocritical care pathways. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based standards. As a dedicated medical tourism agency, we facilitate seamless access for international patients: verifying hospital credentials, coordinating appointments with certified neurointensivists and neurosurgeons, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and medical translation to post-discharge rehabilitation planning.
Intracerebral hemorrhage: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Intracerebral Hemorrhage (Neurology Department)
Non-Surgical / Conservative Management
*Indicated for small-volume hemorrhages (<30 mL), deep or lobar locations without mass effect, GCS ≥13, stable vital signs, and absence of herniation.*
- •Acute Blood Pressure Control: IV nicardipine or labetalol infusion (24–72 hrs) — $85–$120
- •ICP Monitoring & Neuroprotective Care: External ventricular drain (EVD) placement + continuous ICP monitoring (48–96 hrs) — $320–$480
- •Diagnostic Workup: Non-contrast CT brain (baseline + 24-hr follow-up), CBC, coagulation panel (PT/INR, aPTT), renal function, electrolytes — $110–$160
- •Rehabilitation Initiation (Days 3–7): Neurological assessment, early mobilization, speech/swallow evaluation — $240–$360
Surgical / Interventional Management
*Eligible for supratentorial hemorrhage >30 mL with midline shift ≥5 mm, GCS ≤12, or clinical deterioration; cerebellar hemorrhage >3 cm with brainstem compression.*
- •Craniotomy + Hematoma Evacuation: Standard open surgery (including intraoperative neuro-navigation) — $2,800–$4,100
- •Minimally Invasive Surgery (MIS): Endoscopic evacuation or stereotactic aspiration + thrombolytic (rt-PA) — $1,900–$2,700
- •Preoperative Workup: CT angiography (CTA), ECG, chest X-ray, pre-anesthesia evaluation, blood typing/crossmatch — $290–$410
Special/Complex Condition Management
- •Anticoagulant-Related ICH (e.g., warfarin, DOACs): Vitamin K + PCC (4-factor) + reversal monitoring — $420–$650
- •Hypertensive Encephalopathy + ICH: Dual-target BP control (MAP reduction ≤25% in 1 hr) + ICU neuro-monitoring (72 hrs) — $1,350–$1,980
- •Recurrent ICH with Cerebral Amyloid Angiopathy (CAA): Strict BP control (<130/80 mmHg), avoidance of antiplatelets/anticoagulants, long-term outpatient neurology follow-up — $180–$260/month
Quick Selection Guide
- •Age <60, GCS ≥14, volume <25 mL: Conservative management ($750–$1,100 total) — optimal for functional recovery and cost efficiency.
- •Age 60–75, GCS 9–12, volume 35–50 mL, no comorbidities: MIS evacuation ($2,200–$3,100 total) — balances efficacy, reduced trauma, and faster rehab.
- •Age ≥75, GCS ≤8, cerebellar hemorrhage with hydrocephalus: Craniotomy + EVD ($3,800–$5,200 total) — life-saving despite higher risk; avoids rapid decompensation.
- •Warfarin-associated ICH + INR >3.0: Urgent reversal + conservative care ($1,200–$1,800 total) — avoids surgical risk while correcting coagulopathy.
- •Severe comorbidities (e.g., NYHA III–IV HF, eGFR <30 mL/min): Palliative neurocritical care pathway ($900–$1,400 total) — focuses on symptom control and family counseling.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Intracerebral hemorrhage Medical Vacation Packages
Curated transparent all-inclusive packages combining Intracerebral hemorrhage treatment with China top medical destinations:
